June Raine, MHRA CEO (AP Photo/Frank Augstein, Pool)
UK relies on EMA's review of Xgeva reformulation in first-ever reciprocal approval
For the first time since Brexit, the UK’s medicines regulator has made use of its new approval pathway that can speed drug approvals based on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
